SRC3 Cancer Research Results

SRC3, steroid receptor coactivator-3: Click to Expand ⟱
Source:
Type:

SRC-3 (steroid receptor coactivator-3; NCOA3; AIB1) is a transcriptional coactivator encoded by the NCOA3 gene. It does not function as a steroid receptor itself; instead, it binds activated nuclear receptors and other transcription factors and enhances expression of genes involved in proliferation, metabolism, survival, migration and invasion. SRC-3 is frequently amplified, overexpressed or excessively activated in cancer, particularly breast cancer, and can promote estrogen-receptor signaling, PI3K/AKT signaling, growth-factor responses, epithelial–mesenchymal transition, metastasis and resistance to endocrine or anticancer therapy. The typical cancer-associated direction is up, while the desired anticancer modulation is generally down, functional inhibition or protein degradation.



Scientific Papers found: Click to Expand⟱
7060- GamB,    New targets for the antitumor activity of gambogic acid in hematologic malignancies
- Review, Melanoma, RPMI-8226
AntiCan↑, TumCP↓, Apoptosis↑, SRC3↓, DIDO1/DIO-1↑, KCNH2/hERG↓, ROS↑, Bcl-2↓, P53↑, cMyc↓, VEGF↓, Casp3↑, cl‑PARP1↑, eff↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

DIDO1/DIO-1↑, 1,   KCNH2/hERG↓, 1,   SRC3↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

ROS↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

cMyc↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 1,   Bcl-2↓, 1,   Casp3↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

P53↑, 1,   cl‑PARP1↑, 1,  

Migration(tgid=13) ⓘ

TumCP↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

VEGF↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

eff↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 1,  
Total Targets: 14

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: SRC3, steroid receptor coactivator-3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1571  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page